| 1 | clinicaltrials.gov | 7,846 |
| 2 | www.clinicaltrials.gov | 766 |
| 3 | eudract | 280 |
| 4 | controlled-trials.com | 167 |
| 5 | clinicaltrial.gov | 142 |
| 6 | umin | 111 |
| 7 | prospero | 102 |
| 8 | isrctn.org | 76 |
| 9 | clinicaltrials | 68 |
| 10 | gov | 52 |
| 11 | www.trialregister.nl | 44 |
| 12 | anzctr.org.au | 38 |
| 13 | trialregister.nl | 37 |
| 14 | acad | 34 |
| 15 | ukcrn | 33 |
| 16 | www.anzctr.org.au | 33 |
| 17 | umin-ctr | 30 |
| 18 | irct | 26 |
| 19 | springerlink | 23 |
| 20 | vomi | 23 |
| 21 | www.isrctn.org | 20 |
| 22 | japic | 18 |
| 23 | flexpro | 17 |
| 24 | information- | 17 |
| 25 | ctri | 14 |
| 26 | tritici | 14 |
| 27 | www.clinicaltrial.gov | 14 |
| 28 | clinicaltrails.gov | 11 |
| 29 | clintrials.gov | 11 |
| 30 | uniprot | 11 |
| 31 | verruculosa | 11 |
| 32 | clincaltrials.gov | 10 |
| 33 | clincialtrials.gov | 10 |
| 34 | irct.ir | 10 |
| 35 | maladie | 10 |
| 36 | rgd-fsp | 10 |
| 37 | isrct | 9 |
| 38 | chictr.org | 8 |
| 39 | clinicaltrials.org | 8 |
| 40 | clinicaltrialsregister.eu | 8 |
| 41 | controlledtrials.com | 7 |
| 42 | hpct | 7 |
| 43 | umin.ac.jp/ctr | 7 |
| 44 | actr | 6 |
| 45 | c1a60 | 6 |
| 46 | ccmo | 6 |
| 47 | ecad | 6 |
| 48 | www.controlled-trials.com/isrctn | 6 |
| 49 | 2d-3d | 5 |
| 50 | clinicaltrials.govid | 5 |
| 51 | clinicaltrialsgov | 5 |
| 52 | clinicialtrials.gov | 5 |
| 53 | combiflam® | 5 |
| 54 | duboisii | 5 |
| 55 | eudract-number | 5 |
| 56 | eudract.ema.europa.eu | 5 |
| 57 | isrctn.com | 5 |
| 58 | lb-like | 5 |
| 59 | mandshuricum | 5 |
| 60 | pa2024 | 5 |
| 61 | pcbt-i | 5 |
| 62 | tohex | 5 |
| 63 | umzimba | 5 |
| 64 | who-fc | 5 |
| 65 | www.clinicaltrials.org | 5 |
| 66 | 6cu | 4 |
| 67 | actr.org.au | 4 |
| 68 | anzctr.org | 4 |
| 69 | bh-1 | 4 |
| 70 | clinialtrials.gov | 4 |
| 71 | clinical-trials.gov | 4 |
| 72 | dang-gui-shao-yao-san | 4 |
| 73 | dexedrine | 4 |
| 74 | eghf | 4 |
| 75 | emzl | 4 |
| 76 | eudra-ct | 4 |
| 77 | g13 | 4 |
| 78 | gigauss | 4 |
| 79 | mcapiri-bevacizumab | 4 |
| 80 | moderate-iodine-load | 4 |
| 81 | modi | 4 |
| 82 | normal-flow | 4 |
| 83 | pactr | 4 |
| 84 | respire | 4 |
| 85 | retisert | 4 |
| 86 | rocf | 4 |
| 87 | rsvl | 4 |
| 88 | www.ctri.nic.in | 4 |
| 89 | www.umin.ac.jp/ctr | 4 |
| 90 | 365nm | 3 |
| 91 | actes | 3 |
| 92 | b58 | 3 |
| 93 | caution.the | 3 |
| 94 | clinicaltrial.org | 3 |
| 95 | ctri.nic.in | 3 |
| 96 | d-clip | 3 |
| 97 | dangguijakyak-san | 3 |
| 98 | disabkids | 3 |
| 99 | dotarem | 3 |
| 100 | fido | 3 |
| 101 | flubendazole | 3 |
| 102 | galv | 3 |
| 103 | germanctr.de | 3 |
| 104 | h-clinics | 3 |
| 105 | hkclinicaltrials.com | 3 |
| 106 | ice-l | 3 |
| 107 | inter-modality | 3 |
| 108 | isctrn | 3 |
| 109 | isrctn28051878 | 3 |
| 110 | isrctn78818544 | 3 |
| 111 | isrtcn | 3 |
| 112 | japiccti | 3 |
| 113 | narita | 3 |
| 114 | stallergenes | 3 |
| 115 | sucla2 | 3 |
| 116 | thermochron | 3 |
| 117 | trimethyltin | 3 |
| 118 | vercelli | 3 |
| 119 | visyneral | 3 |
| 120 | www.umin.ac.jp/ctr/ | 3 |
| 121 | xltt | 3 |
| 122 | -623 | 2 |
| 123 | 0.10-0.88 | 2 |
| 124 | 0.1°c/s | 2 |
| 125 | 0.35±0.02 | 2 |
| 126 | 19:194-202. | 2 |
| 127 | 2',4'-bna-aon | 2 |
| 128 | 2,2,4,4-tetramethyl-3-thioxocyclobutanе-1-one | 2 |
| 129 | 2000bar | 2 |
| 130 | 2009-013897-42 | 2 |
| 131 | 5-methyl-1 | 2 |
| 132 | 59:70-96. | 2 |
| 133 | 9-δ-tetrahydrocannabinol | 2 |
| 134 | 9. | 2 |
| 135 | a143-145 | 2 |
| 136 | aah-31 | 2 |
| 137 | abigail | 2 |
| 138 | actrn12609000715279 | 2 |
| 139 | actrn12610000386033 | 2 |
| 140 | actrn12614000083695 | 2 |
| 141 | adhd/add | 2 |
| 142 | aerobiosis | 2 |
| 143 | aetoxisclerol | 2 |
| 144 | amyg | 2 |
| 145 | appppa | 2 |
| 146 | argyrophyllum | 2 |
| 147 | asda | 2 |
| 148 | atm2 | 2 |
| 149 | augmentin® | 2 |
| 150 | austriacum | 2 |
| 151 | auy954 | 2 |
| 152 | barsalou | 2 |
| 153 | bcg-russia | 2 |
| 154 | bipolar-unipolar | 2 |
| 155 | c20:2ω6 | 2 |
| 156 | cfpwvcalip | 2 |
| 157 | clinicaltrials.com | 2 |
| 158 | clinicaltrials.gov. | 2 |
| 159 | clinicaltrials.gov.uk | 2 |
| 160 | clinicatrials.gov | 2 |
| 161 | cmt2b1 | 2 |
| 162 | codmn | 2 |
| 163 | corboz | 2 |
| 164 | cornsaff | 2 |
| 165 | cyp24a1rs2585428 | 2 |
| 166 | c₆ | 2 |
| 167 | dahps | 2 |
| 168 | daonil | 2 |
| 169 | diospyrobezoars | 2 |
| 170 | edgewood | 2 |
| 171 | eipl | 2 |
| 172 | emotion-coaching | 2 |
| 173 | ep+ | 2 |
| 174 | fosteum | 2 |
| 175 | franchetii | 2 |
| 176 | gas-bloat | 2 |
| 177 | hillsdale | 2 |
| 178 | hydrogen-1 | 2 |
| 179 | ida-flag | 2 |
| 180 | il28brs12979860 | 2 |
| 181 | ion-1 | 2 |
| 182 | isrctn22608399 | 2 |
| 183 | ivrfretro | 2 |
| 184 | j7 | 2 |
| 185 | kpcg02 | 2 |
| 186 | limb-threat | 2 |
| 187 | lipothymia | 2 |
| 188 | lkyind | 2 |
| 189 | lle-g | 2 |
| 190 | ltac | 2 |
| 191 | luivac | 2 |
| 192 | mutung1 | 2 |
| 193 | myelomatosis | 2 |
| 194 | nct00225797 | 2 |
| 195 | nct00397215 | 2 |
| 196 | nct00692653 | 2 |
| 197 | nct00759434 | 2 |
| 198 | nct00872807 | 2 |
| 199 | nct00973479 | 2 |
| 200 | nct00989417 | 2 |
| 201 | neo-tango | 2 |
| 202 | noise60 | 2 |
| 203 | non-amlodipine-ccbs | 2 |
| 204 | ntr1862 | 2 |
| 205 | ntr2867 | 2 |
| 206 | orofer® | 2 |
| 207 | ows | 2 |
| 208 | oximate | 2 |
| 209 | pardubice | 2 |
| 210 | pfmc | 2 |
| 211 | plumieride | 2 |
| 212 | prof.dr.rd | 2 |
| 213 | progression-to-severe | 2 |
| 214 | pt24 | 2 |
| 215 | publique | 2 |
| 216 | qu-atebs | 2 |
| 217 | rmaov | 2 |
| 218 | roderick | 2 |
| 219 | rs4901706 | 2 |
| 220 | rtpk | 2 |
| 221 | rvrs | 2 |
| 222 | rvwt | 2 |
| 223 | s0008 | 2 |
| 224 | schizophreniaclinicaltrials.gov | 2 |
| 225 | schläfli | 2 |
| 226 | shibire | 2 |
| 227 | shimsco | 2 |
| 228 | siglec12 | 2 |
| 229 | small-extent | 2 |
| 230 | supra-median | 2 |
| 231 | t.p.d | 2 |
| 232 | t2-t0 | 2 |
| 233 | tc-sc | 2 |
| 234 | tnfr-i | 2 |
| 235 | tnxb | 2 |
| 236 | toothpaste/toothbrush | 2 |
| 237 | transmedics | 2 |
| 238 | urealyticus | 2 |
| 239 | vasinfectum | 2 |
| 240 | vc-ventilometer | 2 |
| 241 | www.crd.york.ac.uk/prospero | 2 |
| 242 | yamada | 2 |
| 243 | ∆lvedvi | 2 |
| 244 | 'sphere | 1 |
| 245 | 'walden | 1 |
| 246 | //register.clinicaltrials.gov/prs/app/action/selectprotocol/sid/s0002653/selectaction/view/ts/2/uid/u0000n04 | 1 |
| 247 | //trials.gov | 1 |
| 248 | //www.biomedcentral.com/1741-7015/12/14 | 1 |
| 249 | //www.clinicaltrials.gov.unique | 1 |
| 250 | //www.germanctr.de/ | 1 |
| 251 | //www.umin.ac.jp/ctr/index/htm | 1 |
| 252 | /hypothesis | 1 |
| 253 | 0.56-2.04 | 1 |
| 254 | 05dcz/fhp11 | 1 |
| 255 | 1,170,000 | 1 |
| 256 | 1,400/2,500°c | 1 |
| 257 | 1-12. | 1 |
| 258 | 1-16.9 | 1 |
| 259 | 1.02-7.22 | 1 |
| 260 | 1.23±0.13 | 1 |
| 261 | 1.27-2.3 | 1 |
| 262 | 1.5±1.9 | 1 |
| 263 | 115-121. | 1 |
| 264 | 12.6+/-3.4 | 1 |
| 265 | 12605000422628 | 1 |
| 266 | 15fk20 | 1 |
| 267 | 165-189 | 1 |
| 268 | 169-171 | 1 |
| 269 | 188°c | 1 |
| 270 | 2-aminothiophenol | 1 |
| 271 | 2-arylidene-1-tetralones | 1 |
| 272 | 2-d-to-3-d | 1 |
| 273 | 2-hydroxy-3-carboxymuconate | 1 |
| 274 | 2-mercaptoimidazoles | 1 |
| 275 | 2.0725 | 1 |
| 276 | 2.6±2.2 | 1 |
| 277 | 2.72±1.01 | 1 |
| 278 | 2.95±0.94 | 1 |
| 279 | 20/145 | 1 |
| 280 | 2005-005534-12clinicaltrials.gov | 1 |
| 281 | 2009-016840-38 | 1 |
| 282 | 2011-a00046-35clinicaltrials.gov | 1 |
| 283 | 2012.clinicaltrials.gov | 1 |
| 284 | 21.3°c | 1 |
| 285 | 25,787 | 1 |
| 286 | 25-10-2005 | 1 |
| 287 | 27-4.91 | 1 |
| 288 | 2dus-spect | 1 |
| 289 | 3,5,4'-trihydroxy-6,7-methylenedioxyflavone | 1 |
| 290 | 30610/rtog | 1 |
| 291 | 34-0.97 | 1 |
| 292 | 34.9° | 1 |
| 293 | 386-401. | 1 |
| 294 | 3ª | 1 |
| 295 | 44-46°c | 1 |
| 296 | 456-470. | 1 |
| 297 | 6.7±5.3 | 1 |
| 298 | 607-629 | 1 |
| 299 | 631-633 | 1 |
| 300 | 6:39-52. | 1 |
| 301 | 72-20 | 1 |
| 302 | 8.15±2.59 | 1 |
| 303 | 81/08 | 1 |
| 304 | 844,56 | 1 |
| 305 | 9751/2012 | 1 |
| 306 | abcg9pro | 1 |
| 307 | abstrac | 1 |
| 308 | acenac-mr. | 1 |
| 309 | acrostichum | 1 |
| 310 | activetens | 1 |
| 311 | actrn12607000010493http | 1 |
| 312 | actrn12610001005044 | 1 |
| 313 | actrn12611000353998 | 1 |
| 314 | actrn12611000536965url | 1 |
| 315 | actrn12614000339651date | 1 |
| 316 | adhdrs-parent | 1 |
| 317 | adjuv* | 1 |
| 318 | africa.clinicaltrials.gov | 1 |
| 319 | age/diabetes | 1 |
| 320 | aims/objectives/purpose | 1 |
| 321 | alterfractionation | 1 |
| 322 | amikacin-ceftazidime | 1 |
| 323 | amino-polypeptide | 1 |
| 324 | arousal/hour | 1 |
| 325 | atra-resistant | 1 |
| 326 | background/aim | 1 |
| 327 | background/introduction | 1 |
| 328 | background/motivation | 1 |
| 329 | backgroundbackground | 1 |
| 330 | backgroundl | 1 |
| 331 | bailly | 1 |
| 332 | beeram | 1 |
| 333 | benefits/harms/costs | 1 |
| 334 | bioz | 1 |
| 335 | carboxa | 1 |
| 336 | carvalho | 1 |
| 337 | caution.although | 1 |
| 338 | cc-score | 1 |
| 339 | cconclusion | 1 |
| 340 | chemother* | 1 |
| 341 | chemotherapy-initiated | 1 |
| 342 | chictr-trc- | 1 |
| 343 | chictr-trc-11001201 | 1 |
| 344 | clinical.gov | 1 |
| 345 | clinicaltrail.gov | 1 |
| 346 | clinicaltrial.gov-identifier | 1 |
| 347 | clinicaltrial.govnumber | 1 |
| 348 | clinicaltrials.gov.identifier | 1 |
| 349 | clinicaltrials.govas | 1 |
| 350 | clinicaltrials.in.th | 1 |
| 351 | clinicaltrials.partners.org | 1 |
| 352 | cliniclatrials.gov | 1 |
| 353 | clintrialgov | 1 |
| 354 | cm.methods | 1 |
| 355 | cogscreen | 1 |
| 356 | color-emitting | 1 |
| 357 | conclusiorn | 1 |
| 358 | conclusão | 1 |
| 359 | consort-trial | 1 |
| 360 | context/purpose | 1 |
| 361 | cruk | 1 |
| 362 | cs+ed | 1 |
| 363 | curt. | 1 |
| 364 | cyanidin-3-o-rutinoside | 1 |
| 365 | d-ins+ | 1 |
| 366 | depression-primarycare.org | 1 |
| 367 | design/methods/settings/participants | 1 |
| 368 | design/population | 1 |
| 369 | design/subjects/intervention | 1 |
| 370 | designs/endpoints | 1 |
| 371 | desogrestrel | 1 |
| 372 | dimetinden/ranitidine | 1 |
| 373 | discussion-conclusions | 1 |
| 374 | discusssion/conclusions | 1 |
| 375 | disscussion | 1 |
| 376 | dmard-failures | 1 |
| 377 | docox/docox+c | 1 |
| 378 | drks00000537 | 1 |
| 379 | e-lites | 1 |
| 380 | enemator | 1 |
| 381 | eudra-ct-number | 1 |
| 382 | eudract-aifa | 1 |
| 383 | eudract2007-006087-30 | 1 |
| 384 | eudract2009-011264-11 | 1 |
| 385 | f1d-mc-hgjz | 1 |
| 386 | fluprednidene | 1 |
| 387 | folfiri+bev | 1 |
| 388 | forenames | 1 |
| 389 | funder-driven | 1 |
| 390 | gemma | 1 |
| 391 | gly16-glu27-thr164 | 1 |
| 392 | gona | 1 |
| 393 | group-cd | 1 |
| 394 | group-uf | 1 |
| 395 | gstm1-and/or | 1 |
| 396 | hallahan | 1 |
| 397 | hansson | 1 |
| 398 | heracleumpersicum | 1 |
| 399 | hermetically-sealed | 1 |
| 400 | hkclinicaltrial.com | 1 |
| 401 | hmfg1/g2 | 1 |
| 402 | hp-mb3 | 1 |
| 403 | htpp | 1 |
| 404 | hypercholestero-laemia | 1 |
| 405 | hypotheses/purpose | 1 |
| 406 | id_rcb | 1 |
| 407 | image-to-image | 1 |
| 408 | immersion-pattern | 1 |
| 409 | information-double-blind | 1 |
| 410 | intervention-measurements | 1 |
| 411 | intervention/comparison | 1 |
| 412 | intervention/exposition | 1 |
| 413 | intervention/main | 1 |
| 414 | interventionclinicaltrials.gov | 1 |
| 415 | interventions/outcomes | 1 |
| 416 | isrct.org | 1 |
| 417 | isrctn04631728- | 1 |
| 418 | isrctn16823487 | 1 |
| 419 | isrctn35317141 | 1 |
| 420 | isrctn48473735 | 1 |
| 421 | isrctn50512934 | 1 |
| 422 | isrctn52854353 | 1 |
| 423 | isrctn66330584 | 1 |
| 424 | isrctn69423238 | 1 |
| 425 | isrctn76120052 | 1 |
| 426 | isrctn76460837 | 1 |
| 427 | isrctn78805636 | 1 |
| 428 | isrctn81818945 | 1 |
| 429 | isrctn92443999 | 1 |
| 430 | isrctn93702927 | 1 |
| 431 | jørgensen | 1 |
| 432 | kclinicaltrials.com | 1 |
| 433 | kctr.se | 1 |
| 434 | kq4 | 1 |
| 435 | lanchote | 1 |
| 436 | libr/h2o | 1 |
| 437 | limitations/lessons | 1 |
| 438 | liver-only-metastases | 1 |
| 439 | lundbecktrials.com | 1 |
| 440 | lvedvimri | 1 |
| 441 | lvesvimri | 1 |
| 442 | mabille | 1 |
| 443 | materials/methods | 1 |
| 444 | mazout | 1 |
| 445 | medication-fd | 1 |
| 446 | mehtod | 1 |
| 447 | mehtods | 1 |
| 448 | mesquita | 1 |
| 449 | metacard | 1 |
| 450 | methods-design | 1 |
| 451 | methodsl | 1 |
| 452 | metodology | 1 |
| 453 | miocardiopathy | 1 |
| 454 | mresults | 1 |
| 455 | métodos | 1 |
| 456 | n-cyanoimidazole | 1 |
| 457 | n=475,838 | 1 |
| 458 | na/nh3 | 1 |
| 459 | nap/wake | 1 |
| 460 | nct00183417 | 1 |
| 461 | nct00206310-http | 1 |
| 462 | nct00220974 | 1 |
| 463 | nct00321906 | 1 |
| 464 | nct00393952/eudract | 1 |
| 465 | nct00449488 | 1 |
| 466 | nct00466193 | 1 |
| 467 | nct00513422 | 1 |
| 468 | nct00520819 | 1 |
| 469 | nct00628095 | 1 |
| 470 | nct00628342 | 1 |
| 471 | nct00655369 | 1 |
| 472 | nct00687076 | 1 |
| 473 | nct00744315 | 1 |
| 474 | nct00852852 | 1 |
| 475 | nct00987285 | 1 |
| 476 | nct01130311 | 1 |
| 477 | nct01132248 | 1 |
| 478 | nct01140282 | 1 |
| 479 | nct01141608 | 1 |
| 480 | nct01176565 | 1 |
| 481 | nct01396928 | 1 |
| 482 | nct01432145 | 1 |
| 483 | nct01447966 | 1 |
| 484 | nct01556763 | 1 |
| 485 | nct01722539 | 1 |
| 486 | nct01785290.eudract | 1 |
| 487 | nct01859429 | 1 |
| 488 | nct02164604 | 1 |
| 489 | neuroischemia | 1 |
| 490 | nicomorphine | 1 |
| 491 | nmrr-08-287-1442trial | 1 |
| 492 | nonmacrolides | 1 |
| 493 | nsgo-ec-0302.eudract | 1 |
| 494 | obfectives | 1 |
| 495 | objetivos | 1 |
| 496 | octenidine-gel®/gauze | 1 |
| 497 | op36 | 1 |
| 498 | or=3.74 | 1 |
| 499 | p-nitrophenyl-α-d-glucopyranoside | 1 |
| 500 | palacos-gentamycin-cement | 1 |
| 501 | participants/setting/intervention | 1 |
| 502 | pas-staining | 1 |
| 503 | pbbr1mcs5 | 1 |
| 504 | pd/t2w | 1 |
| 505 | percent/all | 1 |
| 506 | perviridis | 1 |
| 507 | ph≥7.00 | 1 |
| 508 | pioneeristic | 1 |
| 509 | placbo | 1 |
| 510 | plasma-fibrin | 1 |
| 511 | pletysmography | 1 |
| 512 | pnpxyl | 1 |
| 513 | point-per-point | 1 |
| 514 | poly-inosinic | 1 |
| 515 | pre-radiographic | 1 |
| 516 | primaire | 1 |
| 517 | pro08080012clinicaltrials.gov | 1 |
| 518 | processo | 1 |
| 519 | r01- | 1 |
| 520 | r2-values | 1 |
| 521 | ramadurg | 1 |
| 522 | rank=3registry | 1 |
| 523 | re-imbursed | 1 |
| 524 | restults | 1 |
| 525 | resules | 1 |
| 526 | resulst | 1 |
| 527 | results/measures | 1 |
| 528 | results/recommendations | 1 |
| 529 | rezults | 1 |
| 530 | ribeiro | 1 |
| 531 | rosehips | 1 |
| 532 | résultats | 1 |
| 533 | sanctr | 1 |
| 534 | scandiuzzi | 1 |
| 535 | seffah | 1 |
| 536 | setting/timeline | 1 |
| 537 | shh-induced | 1 |
| 538 | shimotsu | 1 |
| 539 | silveira | 1 |
| 540 | skincerity® | 1 |
| 541 | speedometer | 1 |
| 542 | spum-acs | 1 |
| 543 | superoleophilic | 1 |
| 544 | ta.methods | 1 |
| 545 | time.clinicaltrials.gov | 1 |
| 546 | tin-filter | 1 |
| 547 | tj-126 | 1 |
| 548 | toluenesulfonate | 1 |
| 549 | toxicity.clinicaltrials.gov | 1 |
| 550 | trialregister.nlidentifier | 1 |
| 551 | trialregno | 1 |
| 552 | trifluoromethyltrimethylsilane | 1 |
| 553 | tylan | 1 |
| 554 | uddin | 1 |
| 555 | udp-galnac | 1 |
| 556 | umin.ac.jp | 1 |
| 557 | untreated-pbmcs | 1 |
| 558 | vikse | 1 |
| 559 | vitadur-n | 1 |
| 560 | weel | 1 |
| 561 | www.centerwatch | 1 |
| 562 | www.centerwatch.com | 1 |
| 563 | www.chictr.org/cn | 1 |
| 564 | www.clinicaltrials.govnct | 1 |
| 565 | xxxx | 1 |
| 566 | zno-nasrbo3 | 1 |
| 567 | ~3.36 | 1 |
| 568 | α-tubulins | 1 |
| 569 | €5,340 | 1 |
| 570 | | 1 |
| 1 | 'sphere | 1 |
| 2 | 'walden | 1 |
| 3 | -623 | 2 |
| 4 | //register.clinicaltrials.gov/prs/app/action/selectprotocol/sid/s0002653/selectaction/view/ts/2/uid/u0000n04 | 1 |
| 5 | //trials.gov | 1 |
| 6 | //www.biomedcentral.com/1741-7015/12/14 | 1 |
| 7 | //www.clinicaltrials.gov.unique | 1 |
| 8 | //www.germanctr.de/ | 1 |
| 9 | //www.umin.ac.jp/ctr/index/htm | 1 |
| 10 | /hypothesis | 1 |
| 11 | 0.10-0.88 | 2 |
| 12 | 0.1°c/s | 2 |
| 13 | 0.35±0.02 | 2 |
| 14 | 0.56-2.04 | 1 |
| 15 | 05dcz/fhp11 | 1 |
| 16 | 1,170,000 | 1 |
| 17 | 1,400/2,500°c | 1 |
| 18 | 1-12. | 1 |
| 19 | 1-16.9 | 1 |
| 20 | 1.02-7.22 | 1 |
| 21 | 1.23±0.13 | 1 |
| 22 | 1.27-2.3 | 1 |
| 23 | 1.5±1.9 | 1 |
| 24 | 115-121. | 1 |
| 25 | 12.6+/-3.4 | 1 |
| 26 | 12605000422628 | 1 |
| 27 | 15fk20 | 1 |
| 28 | 165-189 | 1 |
| 29 | 169-171 | 1 |
| 30 | 188°c | 1 |
| 31 | 19:194-202. | 2 |
| 32 | 2',4'-bna-aon | 2 |
| 33 | 2,2,4,4-tetramethyl-3-thioxocyclobutanе-1-one | 2 |
| 34 | 2-aminothiophenol | 1 |
| 35 | 2-arylidene-1-tetralones | 1 |
| 36 | 2-d-to-3-d | 1 |
| 37 | 2-hydroxy-3-carboxymuconate | 1 |
| 38 | 2-mercaptoimidazoles | 1 |
| 39 | 2.0725 | 1 |
| 40 | 2.6±2.2 | 1 |
| 41 | 2.72±1.01 | 1 |
| 42 | 2.95±0.94 | 1 |
| 43 | 20/145 | 1 |
| 44 | 2000bar | 2 |
| 45 | 2005-005534-12clinicaltrials.gov | 1 |
| 46 | 2009-013897-42 | 2 |
| 47 | 2009-016840-38 | 1 |
| 48 | 2011-a00046-35clinicaltrials.gov | 1 |
| 49 | 2012.clinicaltrials.gov | 1 |
| 50 | 21.3°c | 1 |
| 51 | 25,787 | 1 |
| 52 | 25-10-2005 | 1 |
| 53 | 27-4.91 | 1 |
| 54 | 2d-3d | 5 |
| 55 | 2dus-spect | 1 |
| 56 | 3,5,4'-trihydroxy-6,7-methylenedioxyflavone | 1 |
| 57 | 30610/rtog | 1 |
| 58 | 34-0.97 | 1 |
| 59 | 34.9° | 1 |
| 60 | 365nm | 3 |
| 61 | 386-401. | 1 |
| 62 | 3ª | 1 |
| 63 | 44-46°c | 1 |
| 64 | 456-470. | 1 |
| 65 | 5-methyl-1 | 2 |
| 66 | 59:70-96. | 2 |
| 67 | 6.7±5.3 | 1 |
| 68 | 607-629 | 1 |
| 69 | 631-633 | 1 |
| 70 | 6:39-52. | 1 |
| 71 | 6cu | 4 |
| 72 | 72-20 | 1 |
| 73 | 8.15±2.59 | 1 |
| 74 | 81/08 | 1 |
| 75 | 844,56 | 1 |
| 76 | 9-δ-tetrahydrocannabinol | 2 |
| 77 | 9. | 2 |
| 78 | 9751/2012 | 1 |
| 79 | a143-145 | 2 |
| 80 | aah-31 | 2 |
| 81 | abcg9pro | 1 |
| 82 | abigail | 2 |
| 83 | abstrac | 1 |
| 84 | acad | 34 |
| 85 | acenac-mr. | 1 |
| 86 | acrostichum | 1 |
| 87 | actes | 3 |
| 88 | activetens | 1 |
| 89 | actr | 6 |
| 90 | actr.org.au | 4 |
| 91 | actrn12607000010493http | 1 |
| 92 | actrn12609000715279 | 2 |
| 93 | actrn12610000386033 | 2 |
| 94 | actrn12610001005044 | 1 |
| 95 | actrn12611000353998 | 1 |
| 96 | actrn12611000536965url | 1 |
| 97 | actrn12614000083695 | 2 |
| 98 | actrn12614000339651date | 1 |
| 99 | adhd/add | 2 |
| 100 | adhdrs-parent | 1 |
| 101 | adjuv* | 1 |
| 102 | aerobiosis | 2 |
| 103 | aetoxisclerol | 2 |
| 104 | africa.clinicaltrials.gov | 1 |
| 105 | age/diabetes | 1 |
| 106 | aims/objectives/purpose | 1 |
| 107 | alterfractionation | 1 |
| 108 | amikacin-ceftazidime | 1 |
| 109 | amino-polypeptide | 1 |
| 110 | amyg | 2 |
| 111 | anzctr.org | 4 |
| 112 | anzctr.org.au | 38 |
| 113 | appppa | 2 |
| 114 | argyrophyllum | 2 |
| 115 | arousal/hour | 1 |
| 116 | asda | 2 |
| 117 | atm2 | 2 |
| 118 | atra-resistant | 1 |
| 119 | augmentin® | 2 |
| 120 | austriacum | 2 |
| 121 | auy954 | 2 |
| 122 | b58 | 3 |
| 123 | background/aim | 1 |
| 124 | background/introduction | 1 |
| 125 | background/motivation | 1 |
| 126 | backgroundbackground | 1 |
| 127 | backgroundl | 1 |
| 128 | bailly | 1 |
| 129 | barsalou | 2 |
| 130 | bcg-russia | 2 |
| 131 | beeram | 1 |
| 132 | benefits/harms/costs | 1 |
| 133 | bh-1 | 4 |
| 134 | bioz | 1 |
| 135 | bipolar-unipolar | 2 |
| 136 | c1a60 | 6 |
| 137 | c20:2ω6 | 2 |
| 138 | carboxa | 1 |
| 139 | carvalho | 1 |
| 140 | caution.although | 1 |
| 141 | caution.the | 3 |
| 142 | cc-score | 1 |
| 143 | ccmo | 6 |
| 144 | cconclusion | 1 |
| 145 | cfpwvcalip | 2 |
| 146 | chemother* | 1 |
| 147 | chemotherapy-initiated | 1 |
| 148 | chictr-trc- | 1 |
| 149 | chictr-trc-11001201 | 1 |
| 150 | chictr.org | 8 |
| 151 | clincaltrials.gov | 10 |
| 152 | clincialtrials.gov | 10 |
| 153 | clinialtrials.gov | 4 |
| 154 | clinical-trials.gov | 4 |
| 155 | clinical.gov | 1 |
| 156 | clinicaltrail.gov | 1 |
| 157 | clinicaltrails.gov | 11 |
| 158 | clinicaltrial.gov | 142 |
| 159 | clinicaltrial.gov-identifier | 1 |
| 160 | clinicaltrial.govnumber | 1 |
| 161 | clinicaltrial.org | 3 |
| 162 | clinicaltrials | 68 |
| 163 | clinicaltrials.com | 2 |
| 164 | clinicaltrials.gov | 7,846 |
| 165 | clinicaltrials.gov. | 2 |
| 166 | clinicaltrials.gov.identifier | 1 |
| 167 | clinicaltrials.gov.uk | 2 |
| 168 | clinicaltrials.govas | 1 |
| 169 | clinicaltrials.govid | 5 |
| 170 | clinicaltrials.in.th | 1 |
| 171 | clinicaltrials.org | 8 |
| 172 | clinicaltrials.partners.org | 1 |
| 173 | clinicaltrialsgov | 5 |
| 174 | clinicaltrialsregister.eu | 8 |
| 175 | clinicatrials.gov | 2 |
| 176 | clinicialtrials.gov | 5 |
| 177 | cliniclatrials.gov | 1 |
| 178 | clintrialgov | 1 |
| 179 | clintrials.gov | 11 |
| 180 | cm.methods | 1 |
| 181 | cmt2b1 | 2 |
| 182 | codmn | 2 |
| 183 | cogscreen | 1 |
| 184 | color-emitting | 1 |
| 185 | combiflam® | 5 |
| 186 | conclusiorn | 1 |
| 187 | conclusão | 1 |
| 188 | consort-trial | 1 |
| 189 | context/purpose | 1 |
| 190 | controlled-trials.com | 167 |
| 191 | controlledtrials.com | 7 |
| 192 | corboz | 2 |
| 193 | cornsaff | 2 |
| 194 | cruk | 1 |
| 195 | cs+ed | 1 |
| 196 | ctri | 14 |
| 197 | ctri.nic.in | 3 |
| 198 | curt. | 1 |
| 199 | cyanidin-3-o-rutinoside | 1 |
| 200 | cyp24a1rs2585428 | 2 |
| 201 | c₆ | 2 |
| 202 | d-clip | 3 |
| 203 | d-ins+ | 1 |
| 204 | dahps | 2 |
| 205 | dang-gui-shao-yao-san | 4 |
| 206 | dangguijakyak-san | 3 |
| 207 | daonil | 2 |
| 208 | depression-primarycare.org | 1 |
| 209 | design/methods/settings/participants | 1 |
| 210 | design/population | 1 |
| 211 | design/subjects/intervention | 1 |
| 212 | designs/endpoints | 1 |
| 213 | desogrestrel | 1 |
| 214 | dexedrine | 4 |
| 215 | dimetinden/ranitidine | 1 |
| 216 | diospyrobezoars | 2 |
| 217 | disabkids | 3 |
| 218 | discussion-conclusions | 1 |
| 219 | discusssion/conclusions | 1 |
| 220 | disscussion | 1 |
| 221 | dmard-failures | 1 |
| 222 | docox/docox+c | 1 |
| 223 | dotarem | 3 |
| 224 | drks00000537 | 1 |
| 225 | duboisii | 5 |
| 226 | e-lites | 1 |
| 227 | ecad | 6 |
| 228 | edgewood | 2 |
| 229 | eghf | 4 |
| 230 | eipl | 2 |
| 231 | emotion-coaching | 2 |
| 232 | emzl | 4 |
| 233 | enemator | 1 |
| 234 | ep+ | 2 |
| 235 | eudra-ct | 4 |
| 236 | eudra-ct-number | 1 |
| 237 | eudract | 280 |
| 238 | eudract-aifa | 1 |
| 239 | eudract-number | 5 |
| 240 | eudract.ema.europa.eu | 5 |
| 241 | eudract2007-006087-30 | 1 |
| 242 | eudract2009-011264-11 | 1 |
| 243 | f1d-mc-hgjz | 1 |
| 244 | fido | 3 |
| 245 | flexpro | 17 |
| 246 | flubendazole | 3 |
| 247 | fluprednidene | 1 |
| 248 | folfiri+bev | 1 |
| 249 | forenames | 1 |
| 250 | fosteum | 2 |
| 251 | franchetii | 2 |
| 252 | funder-driven | 1 |
| 253 | g13 | 4 |
| 254 | galv | 3 |
| 255 | gas-bloat | 2 |
| 256 | gemma | 1 |
| 257 | germanctr.de | 3 |
| 258 | gigauss | 4 |
| 259 | gly16-glu27-thr164 | 1 |
| 260 | gona | 1 |
| 261 | gov | 52 |
| 262 | group-cd | 1 |
| 263 | group-uf | 1 |
| 264 | gstm1-and/or | 1 |
| 265 | h-clinics | 3 |
| 266 | hallahan | 1 |
| 267 | hansson | 1 |
| 268 | heracleumpersicum | 1 |
| 269 | hermetically-sealed | 1 |
| 270 | hillsdale | 2 |
| 271 | hkclinicaltrial.com | 1 |
| 272 | hkclinicaltrials.com | 3 |
| 273 | hmfg1/g2 | 1 |
| 274 | hp-mb3 | 1 |
| 275 | hpct | 7 |
| 276 | htpp | 1 |
| 277 | hydrogen-1 | 2 |
| 278 | hypercholestero-laemia | 1 |
| 279 | hypotheses/purpose | 1 |
| 280 | ice-l | 3 |
| 281 | id_rcb | 1 |
| 282 | ida-flag | 2 |
| 283 | il28brs12979860 | 2 |
| 284 | image-to-image | 1 |
| 285 | immersion-pattern | 1 |
| 286 | information- | 17 |
| 287 | information-double-blind | 1 |
| 288 | inter-modality | 3 |
| 289 | intervention-measurements | 1 |
| 290 | intervention/comparison | 1 |
| 291 | intervention/exposition | 1 |
| 292 | intervention/main | 1 |
| 293 | interventionclinicaltrials.gov | 1 |
| 294 | interventions/outcomes | 1 |
| 295 | ion-1 | 2 |
| 296 | irct | 26 |
| 297 | irct.ir | 10 |
| 298 | isctrn | 3 |
| 299 | isrct | 9 |
| 300 | isrct.org | 1 |
| 301 | isrctn.com | 5 |
| 302 | isrctn.org | 76 |
| 303 | isrctn04631728- | 1 |
| 304 | isrctn16823487 | 1 |
| 305 | isrctn22608399 | 2 |
| 306 | isrctn28051878 | 3 |
| 307 | isrctn35317141 | 1 |
| 308 | isrctn48473735 | 1 |
| 309 | isrctn50512934 | 1 |
| 310 | isrctn52854353 | 1 |
| 311 | isrctn66330584 | 1 |
| 312 | isrctn69423238 | 1 |
| 313 | isrctn76120052 | 1 |
| 314 | isrctn76460837 | 1 |
| 315 | isrctn78805636 | 1 |
| 316 | isrctn78818544 | 3 |
| 317 | isrctn81818945 | 1 |
| 318 | isrctn92443999 | 1 |
| 319 | isrctn93702927 | 1 |
| 320 | isrtcn | 3 |
| 321 | ivrfretro | 2 |
| 322 | j7 | 2 |
| 323 | japic | 18 |
| 324 | japiccti | 3 |
| 325 | jørgensen | 1 |
| 326 | kclinicaltrials.com | 1 |
| 327 | kctr.se | 1 |
| 328 | kpcg02 | 2 |
| 329 | kq4 | 1 |
| 330 | lanchote | 1 |
| 331 | lb-like | 5 |
| 332 | libr/h2o | 1 |
| 333 | limb-threat | 2 |
| 334 | limitations/lessons | 1 |
| 335 | lipothymia | 2 |
| 336 | liver-only-metastases | 1 |
| 337 | lkyind | 2 |
| 338 | lle-g | 2 |
| 339 | ltac | 2 |
| 340 | luivac | 2 |
| 341 | lundbecktrials.com | 1 |
| 342 | lvedvimri | 1 |
| 343 | lvesvimri | 1 |
| 344 | mabille | 1 |
| 345 | maladie | 10 |
| 346 | mandshuricum | 5 |
| 347 | materials/methods | 1 |
| 348 | mazout | 1 |
| 349 | mcapiri-bevacizumab | 4 |
| 350 | medication-fd | 1 |
| 351 | mehtod | 1 |
| 352 | mehtods | 1 |
| 353 | mesquita | 1 |
| 354 | metacard | 1 |
| 355 | methods-design | 1 |
| 356 | methodsl | 1 |
| 357 | metodology | 1 |
| 358 | miocardiopathy | 1 |
| 359 | moderate-iodine-load | 4 |
| 360 | modi | 4 |
| 361 | mresults | 1 |
| 362 | mutung1 | 2 |
| 363 | myelomatosis | 2 |
| 364 | métodos | 1 |
| 365 | n-cyanoimidazole | 1 |
| 366 | n=475,838 | 1 |
| 367 | na/nh3 | 1 |
| 368 | nap/wake | 1 |
| 369 | narita | 3 |
| 370 | nct00183417 | 1 |
| 371 | nct00206310-http | 1 |
| 372 | nct00220974 | 1 |
| 373 | nct00225797 | 2 |
| 374 | nct00321906 | 1 |
| 375 | nct00393952/eudract | 1 |
| 376 | nct00397215 | 2 |
| 377 | nct00449488 | 1 |
| 378 | nct00466193 | 1 |
| 379 | nct00513422 | 1 |
| 380 | nct00520819 | 1 |
| 381 | nct00628095 | 1 |
| 382 | nct00628342 | 1 |
| 383 | nct00655369 | 1 |
| 384 | nct00687076 | 1 |
| 385 | nct00692653 | 2 |
| 386 | nct00744315 | 1 |
| 387 | nct00759434 | 2 |
| 388 | nct00852852 | 1 |
| 389 | nct00872807 | 2 |
| 390 | nct00973479 | 2 |
| 391 | nct00987285 | 1 |
| 392 | nct00989417 | 2 |
| 393 | nct01130311 | 1 |
| 394 | nct01132248 | 1 |
| 395 | nct01140282 | 1 |
| 396 | nct01141608 | 1 |
| 397 | nct01176565 | 1 |
| 398 | nct01396928 | 1 |
| 399 | nct01432145 | 1 |
| 400 | nct01447966 | 1 |
| 401 | nct01556763 | 1 |
| 402 | nct01722539 | 1 |
| 403 | nct01785290.eudract | 1 |
| 404 | nct01859429 | 1 |
| 405 | nct02164604 | 1 |
| 406 | neo-tango | 2 |
| 407 | neuroischemia | 1 |
| 408 | nicomorphine | 1 |
| 409 | nmrr-08-287-1442trial | 1 |
| 410 | noise60 | 2 |
| 411 | non-amlodipine-ccbs | 2 |
| 412 | nonmacrolides | 1 |
| 413 | normal-flow | 4 |
| 414 | nsgo-ec-0302.eudract | 1 |
| 415 | ntr1862 | 2 |
| 416 | ntr2867 | 2 |
| 417 | obfectives | 1 |
| 418 | objetivos | 1 |
| 419 | octenidine-gel®/gauze | 1 |
| 420 | op36 | 1 |
| 421 | or=3.74 | 1 |
| 422 | orofer® | 2 |
| 423 | ows | 2 |
| 424 | oximate | 2 |
| 425 | p-nitrophenyl-α-d-glucopyranoside | 1 |
| 426 | pa2024 | 5 |
| 427 | pactr | 4 |
| 428 | palacos-gentamycin-cement | 1 |
| 429 | pardubice | 2 |
| 430 | participants/setting/intervention | 1 |
| 431 | pas-staining | 1 |
| 432 | pbbr1mcs5 | 1 |
| 433 | pcbt-i | 5 |
| 434 | pd/t2w | 1 |
| 435 | percent/all | 1 |
| 436 | perviridis | 1 |
| 437 | pfmc | 2 |
| 438 | ph≥7.00 | 1 |
| 439 | pioneeristic | 1 |
| 440 | placbo | 1 |
| 441 | plasma-fibrin | 1 |
| 442 | pletysmography | 1 |
| 443 | plumieride | 2 |
| 444 | pnpxyl | 1 |
| 445 | point-per-point | 1 |
| 446 | poly-inosinic | 1 |
| 447 | pre-radiographic | 1 |
| 448 | primaire | 1 |
| 449 | pro08080012clinicaltrials.gov | 1 |
| 450 | processo | 1 |
| 451 | prof.dr.rd | 2 |
| 452 | progression-to-severe | 2 |
| 453 | prospero | 102 |
| 454 | pt24 | 2 |
| 455 | publique | 2 |
| 456 | qu-atebs | 2 |
| 457 | r01- | 1 |
| 458 | r2-values | 1 |
| 459 | ramadurg | 1 |
| 460 | rank=3registry | 1 |
| 461 | re-imbursed | 1 |
| 462 | respire | 4 |
| 463 | restults | 1 |
| 464 | resules | 1 |
| 465 | resulst | 1 |
| 466 | results/measures | 1 |
| 467 | results/recommendations | 1 |
| 468 | retisert | 4 |
| 469 | rezults | 1 |
| 470 | rgd-fsp | 10 |
| 471 | ribeiro | 1 |
| 472 | rmaov | 2 |
| 473 | rocf | 4 |
| 474 | roderick | 2 |
| 475 | rosehips | 1 |
| 476 | rs4901706 | 2 |
| 477 | rsvl | 4 |
| 478 | rtpk | 2 |
| 479 | rvrs | 2 |
| 480 | rvwt | 2 |
| 481 | résultats | 1 |
| 482 | s0008 | 2 |
| 483 | sanctr | 1 |
| 484 | scandiuzzi | 1 |
| 485 | schizophreniaclinicaltrials.gov | 2 |
| 486 | schläfli | 2 |
| 487 | seffah | 1 |
| 488 | setting/timeline | 1 |
| 489 | shh-induced | 1 |
| 490 | shibire | 2 |
| 491 | shimotsu | 1 |
| 492 | shimsco | 2 |
| 493 | siglec12 | 2 |
| 494 | silveira | 1 |
| 495 | skincerity® | 1 |
| 496 | small-extent | 2 |
| 497 | speedometer | 1 |
| 498 | springerlink | 23 |
| 499 | spum-acs | 1 |
| 500 | stallergenes | 3 |
| 501 | sucla2 | 3 |
| 502 | superoleophilic | 1 |
| 503 | supra-median | 2 |
| 504 | t.p.d | 2 |
| 505 | t2-t0 | 2 |
| 506 | ta.methods | 1 |
| 507 | tc-sc | 2 |
| 508 | thermochron | 3 |
| 509 | time.clinicaltrials.gov | 1 |
| 510 | tin-filter | 1 |
| 511 | tj-126 | 1 |
| 512 | tnfr-i | 2 |
| 513 | tnxb | 2 |
| 514 | tohex | 5 |
| 515 | toluenesulfonate | 1 |
| 516 | toothpaste/toothbrush | 2 |
| 517 | toxicity.clinicaltrials.gov | 1 |
| 518 | transmedics | 2 |
| 519 | trialregister.nl | 37 |
| 520 | trialregister.nlidentifier | 1 |
| 521 | trialregno | 1 |
| 522 | trifluoromethyltrimethylsilane | 1 |
| 523 | trimethyltin | 3 |
| 524 | tritici | 14 |
| 525 | tylan | 1 |
| 526 | uddin | 1 |
| 527 | udp-galnac | 1 |
| 528 | ukcrn | 33 |
| 529 | umin | 111 |
| 530 | umin-ctr | 30 |
| 531 | umin.ac.jp | 1 |
| 532 | umin.ac.jp/ctr | 7 |
| 533 | umzimba | 5 |
| 534 | uniprot | 11 |
| 535 | untreated-pbmcs | 1 |
| 536 | urealyticus | 2 |
| 537 | vasinfectum | 2 |
| 538 | vc-ventilometer | 2 |
| 539 | vercelli | 3 |
| 540 | verruculosa | 11 |
| 541 | vikse | 1 |
| 542 | visyneral | 3 |
| 543 | vitadur-n | 1 |
| 544 | vomi | 23 |
| 545 | weel | 1 |
| 546 | who-fc | 5 |
| 547 | www.anzctr.org.au | 33 |
| 548 | www.centerwatch | 1 |
| 549 | www.centerwatch.com | 1 |
| 550 | www.chictr.org/cn | 1 |
| 551 | www.clinicaltrial.gov | 14 |
| 552 | www.clinicaltrials.gov | 766 |
| 553 | www.clinicaltrials.govnct | 1 |
| 554 | www.clinicaltrials.org | 5 |
| 555 | www.controlled-trials.com/isrctn | 6 |
| 556 | www.crd.york.ac.uk/prospero | 2 |
| 557 | www.ctri.nic.in | 4 |
| 558 | www.isrctn.org | 20 |
| 559 | www.trialregister.nl | 44 |
| 560 | www.umin.ac.jp/ctr | 4 |
| 561 | www.umin.ac.jp/ctr/ | 3 |
| 562 | xltt | 3 |
| 563 | xxxx | 1 |
| 564 | yamada | 2 |
| 565 | zno-nasrbo3 | 1 |
| 566 | ~3.36 | 1 |
| 567 | α-tubulins | 1 |
| 568 | €5,340 | 1 |
| 569 | ∆lvedvi | 2 |
| 570 | | 1 |
| 1 | chemother* | 1 |
| 2 | adjuv* | 1 |
| 3 | ep+ | 2 |
| 4 | d-ins+ | 1 |
| 5 | r01- | 1 |
| 6 | isrctn04631728- | 1 |
| 7 | chictr-trc- | 1 |
| 8 | information- | 17 |
| 9 | 456-470. | 1 |
| 10 | 386-401. | 1 |
| 11 | 115-121. | 1 |
| 12 | 19:194-202. | 2 |
| 13 | 1-12. | 1 |
| 14 | 6:39-52. | 1 |
| 15 | 59:70-96. | 2 |
| 16 | 9. | 2 |
| 17 | acenac-mr. | 1 |
| 18 | curt. | 1 |
| 19 | clinicaltrials.gov. | 2 |
| 20 | //www.germanctr.de/ | 1 |
| 21 | www.umin.ac.jp/ctr/ | 3 |
| 22 | ph≥7.00 | 1 |
| 23 | 1,170,000 | 1 |
| 24 | 72-20 | 1 |
| 25 | 15fk20 | 1 |
| 26 | eudract2007-006087-30 | 1 |
| 27 | €5,340 | 1 |
| 28 | il28brs12979860 | 2 |
| 29 | c1a60 | 6 |
| 30 | noise60 | 2 |
| 31 | t2-t0 | 2 |
| 32 | bh-1 | 4 |
| 33 | 5-methyl-1 | 2 |
| 34 | hydrogen-1 | 2 |
| 35 | ion-1 | 2 |
| 36 | 2.72±1.01 | 1 |
| 37 | chictr-trc-11001201 | 1 |
| 38 | eudract2009-011264-11 | 1 |
| 39 | nct01130311 | 1 |
| 40 | 05dcz/fhp11 | 1 |
| 41 | aah-31 | 2 |
| 42 | isrctn35317141 | 1 |
| 43 | 169-171 | 1 |
| 44 | 27-4.91 | 1 |
| 45 | cmt2b1 | 2 |
| 46 | mutung1 | 2 |
| 47 | 2.6±2.2 | 1 |
| 48 | 0.35±0.02 | 2 |
| 49 | kpcg02 | 2 |
| 50 | 9751/2012 | 1 |
| 51 | siglec12 | 2 |
| 52 | 1.02-7.22 | 1 |
| 53 | nct00513422 | 1 |
| 54 | 2009-013897-42 | 2 |
| 55 | nct00628342 | 1 |
| 56 | isrctn76120052 | 1 |
| 57 | nct00852852 | 1 |
| 58 | ntr1862 | 2 |
| 59 | nct01140282 | 1 |
| 60 | sucla2 | 3 |
| 61 | hmfg1/g2 | 1 |
| 62 | atm2 | 2 |
| 63 | 1.27-2.3 | 1 |
| 64 | 6.7±5.3 | 1 |
| 65 | 1.23±0.13 | 1 |
| 66 | g13 | 4 |
| 67 | -623 | 2 |
| 68 | actrn12610000386033 | 2 |
| 69 | 631-633 | 1 |
| 70 | isrctn52854353 | 1 |
| 71 | nct00692653 | 2 |
| 72 | nct01556763 | 1 |
| 73 | nct00466193 | 1 |
| 74 | hp-mb3 | 1 |
| 75 | na/nh3 | 1 |
| 76 | zno-nasrbo3 | 1 |
| 77 | 12.6+/-3.4 | 1 |
| 78 | 0.56-2.04 | 1 |
| 79 | nct02164604 | 1 |
| 80 | //register.clinicaltrials.gov/prs/app/action/selectprotocol/sid/s0002653/selectaction/view/ts/2/uid/u0000n04 | 1 |
| 81 | //www.biomedcentral.com/1741-7015/12/14 | 1 |
| 82 | pa2024 | 5 |
| 83 | pt24 | 2 |
| 84 | nct00759434 | 2 |
| 85 | isrctn50512934 | 1 |
| 86 | actrn12610001005044 | 1 |
| 87 | isrctn78818544 | 3 |
| 88 | auy954 | 2 |
| 89 | gly16-glu27-thr164 | 1 |
| 90 | or=3.74 | 1 |
| 91 | nct00220974 | 1 |
| 92 | isrctn66330584 | 1 |
| 93 | 2.95±0.94 | 1 |
| 94 | kq4 | 1 |
| 95 | 25-10-2005 | 1 |
| 96 | nct00397215 | 2 |
| 97 | nct00744315 | 1 |
| 98 | 2.0725 | 1 |
| 99 | isrctn48473735 | 1 |
| 100 | a143-145 | 2 |
| 101 | 20/145 | 1 |
| 102 | nct01432145 | 1 |
| 103 | isrctn81818945 | 1 |
| 104 | nct01176565 | 1 |
| 105 | nct00987285 | 1 |
| 106 | nct00628095 | 1 |
| 107 | actrn12614000083695 | 2 |
| 108 | pbbr1mcs5 | 1 |
| 109 | rs4901706 | 2 |
| 110 | nct00321906 | 1 |
| 111 | tj-126 | 1 |
| 112 | ~3.36 | 1 |
| 113 | isrctn78805636 | 1 |
| 114 | op36 | 1 |
| 115 | 844,56 | 1 |
| 116 | nct01447966 | 1 |
| 117 | nct00687076 | 1 |
| 118 | c20:2ω6 | 2 |
| 119 | nct00872807 | 2 |
| 120 | nct00183417 | 1 |
| 121 | nct00989417 | 2 |
| 122 | isrctn93702927 | 1 |
| 123 | drks00000537 | 1 |
| 124 | isrctn76460837 | 1 |
| 125 | ntr2867 | 2 |
| 126 | isrctn16823487 | 1 |
| 127 | 25,787 | 1 |
| 128 | 34-0.97 | 1 |
| 129 | nct00225797 | 2 |
| 130 | j7 | 2 |
| 131 | 81/08 | 1 |
| 132 | s0008 | 2 |
| 133 | nct01141608 | 1 |
| 134 | cyp24a1rs2585428 | 2 |
| 135 | 12605000422628 | 1 |
| 136 | nct01396928 | 1 |
| 137 | 2009-016840-38 | 1 |
| 138 | isrctn69423238 | 1 |
| 139 | n=475,838 | 1 |
| 140 | nct01132248 | 1 |
| 141 | b58 | 3 |
| 142 | isrctn28051878 | 3 |
| 143 | 0.10-0.88 | 2 |
| 144 | nct00449488 | 1 |
| 145 | actrn12611000353998 | 1 |
| 146 | 1.5±1.9 | 1 |
| 147 | 1-16.9 | 1 |
| 148 | nct00520819 | 1 |
| 149 | nct01859429 | 1 |
| 150 | 607-629 | 1 |
| 151 | nct01722539 | 1 |
| 152 | 8.15±2.59 | 1 |
| 153 | nct00655369 | 1 |
| 154 | actrn12609000715279 | 2 |
| 155 | nct00973479 | 2 |
| 156 | 165-189 | 1 |
| 157 | isrctn22608399 | 2 |
| 158 | isrctn92443999 | 1 |
| 159 | umzimba | 5 |
| 160 | yamada | 2 |
| 161 | asda | 2 |
| 162 | eudract-aifa | 1 |
| 163 | hypercholestero-laemia | 1 |
| 164 | neuroischemia | 1 |
| 165 | lipothymia | 2 |
| 166 | bcg-russia | 2 |
| 167 | gemma | 1 |
| 168 | gona | 1 |
| 169 | appppa | 2 |
| 170 | silveira | 1 |
| 171 | verruculosa | 11 |
| 172 | narita | 3 |
| 173 | mesquita | 1 |
| 174 | carboxa | 1 |
| 175 | mcapiri-bevacizumab | 4 |
| 176 | id_rcb | 1 |
| 177 | tnxb | 2 |
| 178 | docox/docox+c | 1 |
| 179 | udp-galnac | 1 |
| 180 | abstrac | 1 |
| 181 | ltac | 2 |
| 182 | luivac | 2 |
| 183 | who-fc | 5 |
| 184 | pre-radiographic | 1 |
| 185 | superoleophilic | 1 |
| 186 | poly-inosinic | 1 |
| 187 | japic | 18 |
| 188 | pioneeristic | 1 |
| 189 | pfmc | 2 |
| 190 | tc-sc | 2 |
| 191 | 1,400/2,500°c | 1 |
| 192 | 21.3°c | 1 |
| 193 | 44-46°c | 1 |
| 194 | 188°c | 1 |
| 195 | 2-d-to-3-d | 1 |
| 196 | t.p.d | 2 |
| 197 | 2d-3d | 5 |
| 198 | acad | 34 |
| 199 | ecad | 6 |
| 200 | moderate-iodine-load | 4 |
| 201 | group-cd | 1 |
| 202 | adhd/add | 2 |
| 203 | cs+ed | 1 |
| 204 | shh-induced | 1 |
| 205 | hermetically-sealed | 1 |
| 206 | re-imbursed | 1 |
| 207 | chemotherapy-initiated | 1 |
| 208 | medication-fd | 1 |
| 209 | clinicaltrials.govid | 5 |
| 210 | information-double-blind | 1 |
| 211 | lkyind | 2 |
| 212 | backgroundbackground | 1 |
| 213 | edgewood | 2 |
| 214 | mehtod | 1 |
| 215 | prof.dr.rd | 2 |
| 216 | metacard | 1 |
| 217 | pardubice | 2 |
| 218 | germanctr.de | 3 |
| 219 | plumieride | 2 |
| 220 | p-nitrophenyl-α-d-glucopyranoside | 1 |
| 221 | cyanidin-3-o-rutinoside | 1 |
| 222 | amino-polypeptide | 1 |
| 223 | image-to-image | 1 |
| 224 | caution.the | 3 |
| 225 | maladie | 10 |
| 226 | nap/wake | 1 |
| 227 | lb-like | 5 |
| 228 | hillsdale | 2 |
| 229 | mabille | 1 |
| 230 | n-cyanoimidazole | 1 |
| 231 | flubendazole | 3 |
| 232 | amikacin-ceftazidime | 1 |
| 233 | trifluoromethyltrimethylsilane | 1 |
| 234 | fluprednidene | 1 |
| 235 | dimetinden/ranitidine | 1 |
| 236 | nicomorphine | 1 |
| 237 | setting/timeline | 1 |
| 238 | dexedrine | 4 |
| 239 | 2,2,4,4-tetramethyl-3-thioxocyclobutanе-1-one | 2 |
| 240 | 3,5,4'-trihydroxy-6,7-methylenedioxyflavone | 1 |
| 241 | 'sphere | 1 |
| 242 | progression-to-severe | 2 |
| 243 | primaire | 1 |
| 244 | shibire | 2 |
| 245 | respire | 4 |
| 246 | cc-score | 1 |
| 247 | kctr.se | 1 |
| 248 | vikse | 1 |
| 249 | hypotheses/purpose | 1 |
| 250 | aims/objectives/purpose | 1 |
| 251 | context/purpose | 1 |
| 252 | actrn12614000339651date | 1 |
| 253 | oximate | 2 |
| 254 | 2-hydroxy-3-carboxymuconate | 1 |
| 255 | toluenesulfonate | 1 |
| 256 | lanchote | 1 |
| 257 | publique | 2 |
| 258 | //www.clinicaltrials.gov.unique | 1 |
| 259 | octenidine-gel®/gauze | 1 |
| 260 | rocf | 4 |
| 261 | cornsaff | 2 |
| 262 | eghf | 4 |
| 263 | group-uf | 1 |
| 264 | lle-g | 2 |
| 265 | ida-flag | 2 |
| 266 | emotion-coaching | 2 |
| 267 | pas-staining | 1 |
| 268 | color-emitting | 1 |
| 269 | 30610/rtog | 1 |
| 270 | depression-primarycare.org | 1 |
| 271 | clinicaltrial.org | 3 |
| 272 | isrctn.org | 76 |
| 273 | www.isrctn.org | 20 |
| 274 | chictr.org | 8 |
| 275 | anzctr.org | 4 |
| 276 | clinicaltrials.org | 8 |
| 277 | www.clinicaltrials.org | 5 |
| 278 | clinicaltrials.partners.org | 1 |
| 279 | isrct.org | 1 |
| 280 | ramadurg | 1 |
| 281 | amyg | 2 |
| 282 | seffah | 1 |
| 283 | www.centerwatch | 1 |
| 284 | caution.although | 1 |
| 285 | toothpaste/toothbrush | 2 |
| 286 | clinicaltrials.in.th | 1 |
| 287 | tnfr-i | 2 |
| 288 | pcbt-i | 5 |
| 289 | tritici | 14 |
| 290 | modi | 4 |
| 291 | duboisii | 5 |
| 292 | franchetii | 2 |
| 293 | schläfli | 2 |
| 294 | vercelli | 3 |
| 295 | vomi | 23 |
| 296 | lvedvimri | 1 |
| 297 | lvesvimri | 1 |
| 298 | ctri | 14 |
| 299 | japiccti | 3 |
| 300 | ∆lvedvi | 2 |
| 301 | scandiuzzi | 1 |
| 302 | roderick | 2 |
| 303 | springerlink | 23 |
| 304 | rtpk | 2 |
| 305 | clinicaltrials.gov.uk | 2 |
| 306 | cruk | 1 |
| 307 | ice-l | 3 |
| 308 | consort-trial | 1 |
| 309 | nmrr-08-287-1442trial | 1 |
| 310 | visyneral | 3 |
| 311 | backgroundl | 1 |
| 312 | weel | 1 |
| 313 | desogrestrel | 1 |
| 314 | abigail | 2 |
| 315 | daonil | 2 |
| 316 | percent/all | 1 |
| 317 | trialregister.nl | 37 |
| 318 | www.trialregister.nl | 44 |
| 319 | 2-aminothiophenol | 1 |
| 320 | 9-δ-tetrahydrocannabinol | 2 |
| 321 | aetoxisclerol | 2 |
| 322 | eipl | 2 |
| 323 | actrn12611000536965url | 1 |
| 324 | methodsl | 1 |
| 325 | rsvl | 4 |
| 326 | pnpxyl | 1 |
| 327 | emzl | 4 |
| 328 | beeram | 1 |
| 329 | dotarem | 3 |
| 330 | background/aim | 1 |
| 331 | 365nm | 3 |
| 332 | www.centerwatch.com | 1 |
| 333 | hkclinicaltrial.com | 1 |
| 334 | isrctn.com | 5 |
| 335 | controlled-trials.com | 167 |
| 336 | controlledtrials.com | 7 |
| 337 | lundbecktrials.com | 1 |
| 338 | clinicaltrials.com | 2 |
| 339 | kclinicaltrials.com | 1 |
| 340 | hkclinicaltrials.com | 3 |
| 341 | //www.umin.ac.jp/ctr/index/htm | 1 |
| 342 | austriacum | 2 |
| 343 | mandshuricum | 5 |
| 344 | heracleumpersicum | 1 |
| 345 | fosteum | 2 |
| 346 | acrostichum | 1 |
| 347 | argyrophyllum | 2 |
| 348 | vasinfectum | 2 |
| 349 | vitadur-n | 1 |
| 350 | hallahan | 1 |
| 351 | supra-median | 2 |
| 352 | tylan | 1 |
| 353 | dangguijakyak-san | 3 |
| 354 | dang-gui-shao-yao-san | 4 |
| 355 | www.chictr.org/cn | 1 |
| 356 | isrtcn | 3 |
| 357 | 'walden | 1 |
| 358 | cogscreen | 1 |
| 359 | jørgensen | 1 |
| 360 | funder-driven | 1 |
| 361 | methods-design | 1 |
| 362 | ctri.nic.in | 3 |
| 363 | www.ctri.nic.in | 4 |
| 364 | intervention/main | 1 |
| 365 | uddin | 1 |
| 366 | umin | 111 |
| 367 | plasma-fibrin | 1 |
| 368 | trimethyltin | 3 |
| 369 | codmn | 2 |
| 370 | 2',4'-bna-aon | 2 |
| 371 | disscussion | 1 |
| 372 | cconclusion | 1 |
| 373 | design/population | 1 |
| 374 | alterfractionation | 1 |
| 375 | background/motivation | 1 |
| 376 | background/introduction | 1 |
| 377 | intervention/exposition | 1 |
| 378 | participants/setting/intervention | 1 |
| 379 | design/subjects/intervention | 1 |
| 380 | thermochron | 3 |
| 381 | intervention/comparison | 1 |
| 382 | hansson | 1 |
| 383 | ukcrn | 33 |
| 384 | immersion-pattern | 1 |
| 385 | conclusiorn | 1 |
| 386 | isctrn | 3 |
| 387 | www.controlled-trials.com/isrctn | 6 |
| 388 | libr/h2o | 1 |
| 389 | placbo | 1 |
| 390 | shimsco | 2 |
| 391 | fido | 3 |
| 392 | neo-tango | 2 |
| 393 | carvalho | 1 |
| 394 | ccmo | 6 |
| 395 | trialregno | 1 |
| 396 | prospero | 102 |
| 397 | www.crd.york.ac.uk/prospero | 2 |
| 398 | ribeiro | 1 |
| 399 | abcg9pro | 1 |
| 400 | flexpro | 17 |
| 401 | ivrfretro | 2 |
| 402 | processo | 1 |
| 403 | conclusão | 1 |
| 404 | cfpwvcalip | 2 |
| 405 | d-clip | 3 |
| 406 | umin.ac.jp | 1 |
| 407 | htpp | 1 |
| 408 | rgd-fsp | 10 |
| 409 | nct00206310-http | 1 |
| 410 | actrn12607000010493http | 1 |
| 411 | 2000bar | 2 |
| 412 | bipolar-unipolar | 2 |
| 413 | eudra-ct-number | 1 |
| 414 | eudract-number | 5 |
| 415 | clinicaltrial.govnumber | 1 |
| 416 | clinicaltrial.gov-identifier | 1 |
| 417 | clinicaltrials.gov.identifier | 1 |
| 418 | trialregister.nlidentifier | 1 |
| 419 | speedometer | 1 |
| 420 | vc-ventilometer | 2 |
| 421 | tin-filter | 1 |
| 422 | irct.ir | 10 |
| 423 | gstm1-and/or | 1 |
| 424 | enemator | 1 |
| 425 | umin-ctr | 30 |
| 426 | umin.ac.jp/ctr | 7 |
| 427 | www.umin.ac.jp/ctr | 4 |
| 428 | actr | 6 |
| 429 | pactr | 4 |
| 430 | sanctr | 1 |
| 431 | arousal/hour | 1 |
| 432 | 0.1°c/s | 2 |
| 433 | clinicaltrials.govas | 1 |
| 434 | non-amlodipine-ccbs | 2 |
| 435 | qu-atebs | 2 |
| 436 | spum-acs | 1 |
| 437 | transmedics | 2 |
| 438 | h-clinics | 3 |
| 439 | untreated-pbmcs | 1 |
| 440 | disabkids | 3 |
| 441 | ta.methods | 1 |
| 442 | cm.methods | 1 |
| 443 | materials/methods | 1 |
| 444 | mehtods | 1 |
| 445 | nonmacrolides | 1 |
| 446 | 2-mercaptoimidazoles | 1 |
| 447 | resules | 1 |
| 448 | forenames | 1 |
| 449 | interventions/outcomes | 1 |
| 450 | stallergenes | 3 |
| 451 | 2-arylidene-1-tetralones | 1 |
| 452 | dmard-failures | 1 |
| 453 | results/measures | 1 |
| 454 | liver-only-metastases | 1 |
| 455 | actes | 3 |
| 456 | age/diabetes | 1 |
| 457 | e-lites | 1 |
| 458 | r2-values | 1 |
| 459 | obfectives | 1 |
| 460 | perviridis | 1 |
| 461 | /hypothesis | 1 |
| 462 | aerobiosis | 2 |
| 463 | myelomatosis | 2 |
| 464 | clinicaltrials | 68 |
| 465 | activetens | 1 |
| 466 | α-tubulins | 1 |
| 467 | discussion-conclusions | 1 |
| 468 | discusssion/conclusions | 1 |
| 469 | results/recommendations | 1 |
| 470 | limitations/lessons | 1 |
| 471 | métodos | 1 |
| 472 | objetivos | 1 |
| 473 | dahps | 2 |
| 474 | rosehips | 1 |
| 475 | diospyrobezoars | 2 |
| 476 | rvrs | 2 |
| 477 | gigauss | 4 |
| 478 | résultats | 1 |
| 479 | mresults | 1 |
| 480 | restults | 1 |
| 481 | rezults | 1 |
| 482 | design/methods/settings/participants | 1 |
| 483 | intervention-measurements | 1 |
| 484 | designs/endpoints | 1 |
| 485 | benefits/harms/costs | 1 |
| 486 | urealyticus | 2 |
| 487 | ows | 2 |
| 488 | limb-threat | 2 |
| 489 | gas-bloat | 2 |
| 490 | eudra-ct | 4 |
| 491 | eudract | 280 |
| 492 | nct01785290.eudract | 1 |
| 493 | nsgo-ec-0302.eudract | 1 |
| 494 | nct00393952/eudract | 1 |
| 495 | 2dus-spect | 1 |
| 496 | www.clinicaltrials.govnct | 1 |
| 497 | hpct | 7 |
| 498 | irct | 26 |
| 499 | isrct | 9 |
| 500 | atra-resistant | 1 |
| 501 | palacos-gentamycin-cement | 1 |
| 502 | adhdrs-parent | 1 |
| 503 | small-extent | 2 |
| 504 | point-per-point | 1 |
| 505 | uniprot | 11 |
| 506 | retisert | 4 |
| 507 | resulst | 1 |
| 508 | xltt | 3 |
| 509 | mazout | 1 |
| 510 | rvwt | 2 |
| 511 | actr.org.au | 4 |
| 512 | anzctr.org.au | 38 |
| 513 | www.anzctr.org.au | 33 |
| 514 | 6cu | 4 |
| 515 | eudract.ema.europa.eu | 5 |
| 516 | clinicaltrialsregister.eu | 8 |
| 517 | barsalou | 2 |
| 518 | shimotsu | 1 |
| 519 | folfiri+bev | 1 |
| 520 | galv | 3 |
| 521 | rmaov | 2 |
| 522 | gov | 52 |
| 523 | clinical.gov | 1 |
| 524 | clinicaltrial.gov | 142 |
| 525 | www.clinicaltrial.gov | 14 |
| 526 | clinicaltrail.gov | 1 |
| 527 | clinical-trials.gov | 4 |
| 528 | //trials.gov | 1 |
| 529 | clinicatrials.gov | 2 |
| 530 | cliniclatrials.gov | 1 |
| 531 | clinicaltrials.gov | 7,846 |
| 532 | 2012.clinicaltrials.gov | 1 |
| 533 | africa.clinicaltrials.gov | 1 |
| 534 | time.clinicaltrials.gov | 1 |
| 535 | www.clinicaltrials.gov | 766 |
| 536 | toxicity.clinicaltrials.gov | 1 |
| 537 | 2005-005534-12clinicaltrials.gov | 1 |
| 538 | pro08080012clinicaltrials.gov | 1 |
| 539 | 2011-a00046-35clinicaltrials.gov | 1 |
| 540 | schizophreniaclinicaltrials.gov | 2 |
| 541 | interventionclinicaltrials.gov | 1 |
| 542 | clincaltrials.gov | 10 |
| 543 | clinicialtrials.gov | 5 |
| 544 | clincialtrials.gov | 10 |
| 545 | clinialtrials.gov | 4 |
| 546 | clintrials.gov | 11 |
| 547 | clinicaltrails.gov | 11 |
| 548 | clintrialgov | 1 |
| 549 | clinicaltrialsgov | 5 |
| 550 | pd/t2w | 1 |
| 551 | normal-flow | 4 |
| 552 | tohex | 5 |
| 553 | xxxx | 1 |
| 554 | metodology | 1 |
| 555 | pletysmography | 1 |
| 556 | miocardiopathy | 1 |
| 557 | bailly | 1 |
| 558 | rank=3registry | 1 |
| 559 | inter-modality | 3 |
| 560 | f1d-mc-hgjz | 1 |
| 561 | corboz | 2 |
| 562 | bioz | 1 |
| 563 | c₆ | 2 |
| 564 | 3ª | 1 |
| 565 | combiflam® | 5 |
| 566 | augmentin® | 2 |
| 567 | orofer® | 2 |
| 568 | skincerity® | 1 |
| 569 | 34.9° | 1 |
| 570 | | 1 |